Heart transplantation keeps its leading position in the treatment of end-stage heart failure
(HF). Survival rates and functional status following heart transplantation are excellent …

Despite advances in medical and device therapy, the prognosis and quality of life of patients
with advanced heart failure (HF) remains poor. For a carefully selected group of these …

Heart transplantation is currently the definitive gold standard surgical approach in the
treatment of refractory heart failure. However, the shortage of donors limits the achievement …

Despite advances in pharmacologic and device treatment of chronic heart failure, long-term
morbidity and mortality remain high, and many patients progress to end-stage heart failure …

▪ Abstract Heart transplantation has evolved over the past 30 years into a mainstay of
therapy for heart failure patients. As the surgical technique and basic immunology were …

Heart transplantation has become a standard therapy option for advanced heart failure. The
translation of heart transplantation from innovative experiments to long-term clinical success …

Heart transplantation (HTx) has become standard treatment for selected patients with end-
stage heart failure. Improvements in immunosuppressant, donor procurement, surgical …

The first human heart transplantation was performed by Christian Barnard in 1967. While the
technical aspect had been worked out, allograft rejection was a major limitation in the early …

Based on the changes in the field of heart transplantation and the treatment and prognosis
of patients with heart failure, these updated guidelines were composed by a committee …

As a consequence of improved management in acute coronary syndromes and improved
longevity of the population, the number of patients with heart failure is growing. The …